Titre : Lame limitante postérieure

Lame limitante postérieure : Questions médicales fréquentes

Termes MeSH sélectionnés :

Probability
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Lame limitante postérieure : Questions médicales les plus fréquentes", "headline": "Lame limitante postérieure : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Lame limitante postérieure : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-30", "dateModified": "2025-04-25", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Lame limitante postérieure" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Membrane basale", "url": "https://questionsmedicales.fr/mesh/D001485", "about": { "@type": "MedicalCondition", "name": "Membrane basale", "code": { "@type": "MedicalCode", "code": "D001485", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A10.615.179" } } }, "about": { "@type": "MedicalCondition", "name": "Lame limitante postérieure", "alternateName": "Descemet Membrane", "code": { "@type": "MedicalCode", "code": "D003886", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Steven E Wilson", "url": "https://questionsmedicales.fr/author/Steven%20E%20Wilson", "affiliation": { "@type": "Organization", "name": "Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA. Electronic address: wilsons4@ccf.org." } }, { "@type": "Person", "name": "Takahiko Hayashi", "url": "https://questionsmedicales.fr/author/Takahiko%20Hayashi", "affiliation": { "@type": "Organization", "name": "Department of Ophthalmology, Nihon University of Medicine, Tokyo, Japan." } }, { "@type": "Person", "name": "Nir Sorkin", "url": "https://questionsmedicales.fr/author/Nir%20Sorkin", "affiliation": { "@type": "Organization", "name": "Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada." } }, { "@type": "Person", "name": "Clara C Chan", "url": "https://questionsmedicales.fr/author/Clara%20C%20Chan", "affiliation": { "@type": "Organization", "name": "Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada." } }, { "@type": "Person", "name": "David S Rootman", "url": "https://questionsmedicales.fr/author/David%20S%20Rootman", "affiliation": { "@type": "Organization", "name": "Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Serum multi-cytokines screening identifies TRAIL and IL-10 as probable new biomarkers for prostate health index diagnostic utility adjustment in grey zone aggressive prostate cancer detection: A single-center data in China.", "datePublished": "2022-08-18", "url": "https://questionsmedicales.fr/article/36059480", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2022.901176" } }, { "@type": "ScholarlyArticle", "name": "Efficacy and safety of switching from intravenous to oral antibiotics (amoxicillin-clavulanic acid) versus a full course of intravenous antibiotics in neonates with probable bacterial infection (RAIN): a multicentre, randomised, open-label, non-inferiority trial.", "datePublished": "2022-09-09", "url": "https://questionsmedicales.fr/article/36088952", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/S2352-4642(22)00245-0" } }, { "@type": "ScholarlyArticle", "name": "'I probably wouldn't want to talk about anything too personal': A qualitative exploration of how issues of privacy, confidentiality and surveillance in the home impact on access and engagement with online services and spaces for care-experienced young people.", "datePublished": "2023-10-19", "url": "https://questionsmedicales.fr/article/37873026", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/03085759231203019" } }, { "@type": "ScholarlyArticle", "name": "Modeling the Probability of HIV Infection over Time in High-Risk Seronegative Participants Receiving Placebo in Five Randomized Double-Blind Placebo-Controlled HIV Pre-Exposure Prophylaxis Trials: A Patient-Level Pooled Analysis.", "datePublished": "2022-08-27", "url": "https://questionsmedicales.fr/article/36145549", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/pharmaceutics14091801" } }, { "@type": "ScholarlyArticle", "name": "Risk and survival of patients with non-small cell lung cancer and pre-existing autoimmune disorders receiving immune checkpoint blockade therapy: Survival analysis with inverse probability weighting from a nationwide, multi-institutional, retrospective study (NEJ047).", "datePublished": "2024-07-14", "url": "https://questionsmedicales.fr/article/39029359", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.lungcan.2024.107894" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Tissus", "item": "https://questionsmedicales.fr/mesh/D014024" }, { "@type": "ListItem", "position": 3, "name": "Membranes", "item": "https://questionsmedicales.fr/mesh/D008566" }, { "@type": "ListItem", "position": 4, "name": "Membrane basale", "item": "https://questionsmedicales.fr/mesh/D001485" }, { "@type": "ListItem", "position": 5, "name": "Lame limitante postérieure", "item": "https://questionsmedicales.fr/mesh/D003886" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Lame limitante postérieure - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Lame limitante postérieure", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Lame limitante postérieure", "description": "Comment diagnostiquer une pathologie de la membrane de Descemet ?\nQuels tests sont utilisés pour évaluer la membrane de Descemet ?\nQuels signes indiquent une défaillance de la membrane de Descemet ?\nLa biopsie est-elle nécessaire pour diagnostiquer des anomalies ?\nQuels symptômes peuvent indiquer un problème avec la membrane de Descemet ?", "url": "https://questionsmedicales.fr/mesh/D003886?mesh_terms=Probability&page=273#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Lame limitante postérieure", "description": "Quels sont les symptômes d'une défaillance de la membrane de Descemet ?\nLa rougeur de l'œil est-elle un symptôme associé ?\nPeut-on ressentir des démangeaisons avec des problèmes de Descemet ?\nLes troubles visuels sont-ils fréquents avec des anomalies de Descemet ?\nLa douleur oculaire est-elle un symptôme courant ?", "url": "https://questionsmedicales.fr/mesh/D003886?mesh_terms=Probability&page=273#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Lame limitante postérieure", "description": "Comment prévenir les problèmes de la membrane de Descemet ?\nLes examens réguliers des yeux sont-ils importants ?\nUne bonne hygiène oculaire peut-elle prévenir des problèmes ?\nLes allergies oculaires peuvent-elles affecter la membrane de Descemet ?\nLe port de lentilles de contact nécessite-t-il des précautions ?", "url": "https://questionsmedicales.fr/mesh/D003886?mesh_terms=Probability&page=273#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Lame limitante postérieure", "description": "Quels traitements sont disponibles pour les problèmes de Descemet ?\nLa greffe de cornée est-elle une option de traitement ?\nLes gouttes oculaires peuvent-elles aider ?\nY a-t-il des traitements non chirurgicaux disponibles ?\nLes traitements varient-ils selon la gravité de la condition ?", "url": "https://questionsmedicales.fr/mesh/D003886?mesh_terms=Probability&page=273#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Lame limitante postérieure", "description": "Quelles complications peuvent survenir avec des problèmes de Descemet ?\nL'infection est-elle une complication possible ?\nLes cicatrices cornéennes peuvent-elles résulter de problèmes de Descemet ?\nPeut-on développer un glaucome à cause de problèmes de Descemet ?\nLes complications peuvent-elles nécessiter une intervention chirurgicale ?", "url": "https://questionsmedicales.fr/mesh/D003886?mesh_terms=Probability&page=273#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Lame limitante postérieure", "description": "Quels sont les facteurs de risque pour les problèmes de Descemet ?\nL'âge est-il un facteur de risque ?\nLes maladies systémiques influencent-elles la santé de Descemet ?\nLe port de lentilles de contact est-il un facteur de risque ?\nLes allergies peuvent-elles être un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D003886?mesh_terms=Probability&page=273#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une pathologie de la membrane de Descemet ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un examen ophtalmologique complet, incluant la tomographie et la microscopie, est essentiel." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la membrane de Descemet ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "La pachymétrie et l'optique cohérente par tomographie sont couramment utilisés." } }, { "@type": "Question", "name": "Quels signes indiquent une défaillance de la membrane de Descemet ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Un œdème cornéen et une opacité cornéenne peuvent signaler une défaillance." } }, { "@type": "Question", "name": "La biopsie est-elle nécessaire pour diagnostiquer des anomalies ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "La biopsie n'est généralement pas nécessaire, les examens non invasifs suffisent." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème avec la membrane de Descemet ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Vision floue, douleur oculaire et rougeur peuvent indiquer un problème." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une défaillance de la membrane de Descemet ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent vision floue, douleur, et sensibilité à la lumière." } }, { "@type": "Question", "name": "La rougeur de l'œil est-elle un symptôme associé ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la rougeur de l'œil peut être un symptôme d'inflammation ou d'irritation." } }, { "@type": "Question", "name": "Peut-on ressentir des démangeaisons avec des problèmes de Descemet ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des démangeaisons peuvent survenir en raison d'irritation ou d'allergies." } }, { "@type": "Question", "name": "Les troubles visuels sont-ils fréquents avec des anomalies de Descemet ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les troubles visuels sont fréquents et peuvent varier en gravité." } }, { "@type": "Question", "name": "La douleur oculaire est-elle un symptôme courant ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la douleur oculaire est un symptôme courant associé aux problèmes de Descemet." } }, { "@type": "Question", "name": "Comment prévenir les problèmes de la membrane de Descemet ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les traumatismes oculaires et porter des lunettes de protection peut aider." } }, { "@type": "Question", "name": "Les examens réguliers des yeux sont-ils importants ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des examens réguliers permettent de détecter précocement les problèmes." } }, { "@type": "Question", "name": "Une bonne hygiène oculaire peut-elle prévenir des problèmes ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, maintenir une bonne hygiène oculaire aide à prévenir les infections et irritations." } }, { "@type": "Question", "name": "Les allergies oculaires peuvent-elles affecter la membrane de Descemet ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les allergies peuvent provoquer des inflammations affectant la membrane." } }, { "@type": "Question", "name": "Le port de lentilles de contact nécessite-t-il des précautions ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il est crucial de suivre les recommandations pour éviter les complications." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les problèmes de Descemet ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des médicaments anti-inflammatoires et des interventions chirurgicales." } }, { "@type": "Question", "name": "La greffe de cornée est-elle une option de traitement ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la greffe de cornée peut être nécessaire en cas de défaillance sévère." } }, { "@type": "Question", "name": "Les gouttes oculaires peuvent-elles aider ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des gouttes oculaires peuvent réduire l'inflammation et améliorer le confort." } }, { "@type": "Question", "name": "Y a-t-il des traitements non chirurgicaux disponibles ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des traitements médicaux et des thérapies de soutien sont disponibles." } }, { "@type": "Question", "name": "Les traitements varient-ils selon la gravité de la condition ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements sont adaptés en fonction de la gravité et des symptômes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des problèmes de Descemet ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'œdème cornéen, la perte de vision et l'infection." } }, { "@type": "Question", "name": "L'infection est-elle une complication possible ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une infection peut survenir, surtout après une chirurgie ou un traumatisme." } }, { "@type": "Question", "name": "Les cicatrices cornéennes peuvent-elles résulter de problèmes de Descemet ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des cicatrices peuvent se former, affectant la clarté de la vision." } }, { "@type": "Question", "name": "Peut-on développer un glaucome à cause de problèmes de Descemet ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des problèmes de Descemet peuvent augmenter le risque de glaucome." } }, { "@type": "Question", "name": "Les complications peuvent-elles nécessiter une intervention chirurgicale ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines complications graves peuvent nécessiter une intervention chirurgicale." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les problèmes de Descemet ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux, les traumatismes oculaires et certaines maladies augmentent le risque." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut augmenter le risque de défaillance de la membrane de Descemet." } }, { "@type": "Question", "name": "Les maladies systémiques influencent-elles la santé de Descemet ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme le diabète peuvent affecter la santé cornéenne." } }, { "@type": "Question", "name": "Le port de lentilles de contact est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un usage inapproprié des lentilles peut augmenter le risque d'infections." } }, { "@type": "Question", "name": "Les allergies peuvent-elles être un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les allergies oculaires peuvent contribuer à l'inflammation et aux problèmes de Descemet." } } ] } ] }

Sources (2727 au total)

Serum multi-cytokines screening identifies TRAIL and IL-10 as probable new biomarkers for prostate health index diagnostic utility adjustment in grey zone aggressive prostate cancer detection: A single-center data in China.

To identify less invasive and easily applicable serum cytokine-derived biomarkers which contribute to the diagnostic utility and risk assessment ability of the prostate health index (PHI) based multiv... Serum 45 cytokines screening was performed in a small training cohort consisting of 10 sera by Luminex liquid array-based multiplexed immunoassays and identified TRAIL and IL-10 as new biomarkers for ... TRAIL and IL-10 were identified as potential serum biomarkers for AG PCa detection by the result of multi-cytokines screening in the univariate analysis, while multivariable logistic regression confir... We suggest a significant advantage for the PHI-based multivariate combinations of serum TRAIL and IL-10 comparing to PHI or other serum-derived biomarkers alone in the detection and risk stratificatio...

Efficacy and safety of switching from intravenous to oral antibiotics (amoxicillin-clavulanic acid) versus a full course of intravenous antibiotics in neonates with probable bacterial infection (RAIN): a multicentre, randomised, open-label, non-inferiority trial.

Switching from intravenous antibiotic therapy to oral antibiotic therapy among neonates is not yet practised in high-income settings due to uncertainties about exposure and safety. We aimed to assess ... In this multicentre, randomised, open-label, non-inferiority trial, patients were recruited at 17 hospitals in the Netherlands. Neonates (postmenstrual age ≥35 weeks, postnatal age 0-28 days, bodyweig... Between Feb 8, 2018 and May 12, 2021, 510 neonates were randomly assigned (n=255 oral amoxicillin-clavulanic group; n=255 intravenous antibiotic group). After excluding those who withdrew consent (n=4... An early intravenous-to-oral antibiotic switch with amoxicillin-clavulanic acid is non-inferior to a full course of intravenous antibiotics in neonates with probable bacterial infection and is not ass... The Netherlands Organization for Health Research and Development, Innovatiefonds Zorgverzekeraars, and the Sophia Foundation for Scientific Research....

'I probably wouldn't want to talk about anything too personal': A qualitative exploration of how issues of privacy, confidentiality and surveillance in the home impact on access and engagement with online services and spaces for care-experienced young people.

This paper draws on a qualitative interview-based study that explored online mental health and wellbeing interventions and services for care-experienced young people. The study involved young people (...

Risk and survival of patients with non-small cell lung cancer and pre-existing autoimmune disorders receiving immune checkpoint blockade therapy: Survival analysis with inverse probability weighting from a nationwide, multi-institutional, retrospective study (NEJ047).

The risk and survival of patients with non-small cell lung cancer (NSCLC) with pre-existing autoimmune disorders (AIDs) receiving immune checkpoint blockade (ICB) therapy have not been clearly establi... This multi-institutional, retrospective cohort study was conducted in collaboration with 20 centers in Japan.... In total, 229 patients with advanced or recurrent NSCLC and pre-existing AID, with or without ICB treatment from January 2010-February 2020, were included and analyzed. Among 69 patients who received ... These findings revealed a novel risk factor for AID flares following ICB treatment, that is the diagnosis of NSCLC within 1 year of AID diagnosis, and showed that ICBs may improve survival in this pop...

Mandibular dose-volume predicts time-to-osteoradionecrosis in an actuarial normal-tissue complication probability (NTCP) model: External validation of right-censored clinico-dosimetric and competing risk application across international multi-institutional observational cohorts and online graphical user interface clinical support tool assessment.

Existing studies on osteoradionecrosis of the jaw (ORNJ) have primarily used cross-sectional data, assessing risk factors at a single time point. Determining the time-to-event profile of ORNJ has impo... Demographic, clinical and dosimetric data were retrospectively obtained for a clinical observational cohort of 1129 patients with HNC treated with radiotherapy (RT) at The University of Texas MD Ander... Our model identified that each unit increase in D25% is significantly associated with a 12% shorter time to ORNJ (Adjusted Time Ratio [ATR] 0·88, p<0·005); pre-RT dental extractions was associated to ... This study is the first to demonstrate a direct relationship between radiation dose and the time to ORNJ onset, providing a novel characterization of the impact of delivered dose not only on the proba... This work was supported by various funding sources including NIH, NIDCR, NCI, NAPT, NASA, BCM, Affirmed Pharma, CRUK, KWF Dutch Cancer Society, NWO ZonMw, and the Apache Corporation....

The World Health Organization Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns (ACTION-III) Trial: study protocol for a multi-country, multi-centre, double-blind, three-arm, placebo-controlled, individually randomized trial of antenatal corticosteroids for women at high probability of late preterm birth in hospitals in low- resource countries.

Preterm birth complications are the leading cause of newborn and under-5 mortality. Over 85% of all preterm births occur in the late preterm period, i.e. between 34 and < 37 weeks of gestation. Antena... WHO ACTION III trial is a parallel-group, three-arm, individually randomized, double-blind, placebo-controlled trial of two ACS regimens: dexamethasone phosphate 4 × 6 mg q12h or betamethasone phospha... This trial will evaluate the benefits and possible harms of ACS when used in women likely to have a late preterm birth. It will also evaluate a lower-dose ACS regimen based on literature from pharmaco... ISRCTN11434567 . Registered on 7 June 2021....